Cargando…
Zoster vaccine live for the prevention of shingles in the elderly patient
Shingles, also known as herpes zoster, is a common disease in the elderly population that is caused by reactivation of latent varicella zoster virus. Its manifestations and complications can lead to significant short- and long-term morbidity. In 2006, the United States Food and Drug Administration a...
Autores principales: | Zussman, Jamie, Young, Lorraine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546469/ https://www.ncbi.nlm.nih.gov/pubmed/18686747 |
Ejemplares similares
-
Prevention of shingles: safety and efficacy of live zoster vaccine
por: Quan, Dianna, et al.
Publicado: (2007) -
Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
por: Baxter, Roger, et al.
Publicado: (2018) -
Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
por: Lee, Eunyoung, et al.
Publicado: (2018) -
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine
por: Litt, John, et al.
Publicado: (2020) -
Shingles (Herpes Zoster) Mimicking Acute Abdomen
por: Monib, Sherif, et al.
Publicado: (2020)